Novavax, Inc. faces declining revenues and high risks despite the Sanofi deal and cost-cutting measures. Click here for my post earnings update for NVAX stock.

Sanofi India share price gained up to 6% in morning trades on Friday post Q4 results announced by the company after the market hours on Thursday. Sanofi India also announced dividend of ₹117 per share ...

Sanofi Consumer Healthcare India Q4 Results 2025:Sanofi Consumer Healthcare India declared their Q4 results on 20 Feb, 2025. The topline decreased by 20.53% year-over-year (YoY), with profit ...

Novavax Inc (NVAX) outlines its strategic focus on partnerships and pipeline expansion while navigating revenue fluctuations and operational transitions.

Sanofi Indias standalone net profit jumped 31% Rs 91.3 crore in Q4 FY25 as compared with Rs 69.7 crore in Q4 FY24. Revenue increased 9.7% YoY to Rs 514.9 crore in Q4 FY25.

Zacks Research also issued estimates for Sanofi’s Q4 2025 earnings at $0.80 EPS, FY2025 earnings at $4.14 EPS, Q1 2026 earnings at $1.00 EPS, Q3 2026 earnings at $1.36 EPS, Q4 2026 earnings at $ ...

Novavax (NVAX) stock jumped today following the release of the vaccine maker’s Q4 2024 earnings report. That follows its diluted earnings per ...

Sanofi reported in its Q4 2024 results that Dupixent surpassed its €13bn ($13.6bn) sales target for the full year, reaching $14.15bn sales. According to GlobalData’s Pharma Intelligence Center ...

With a market valuation of Rs 11,574.76 Cr, Sanofi Indias shares ended Fridays trading session on the BSE 0.58% higher at Rs ...

Novavax Inc. (NVAX) shares climbed over 1% in after-hours trading Thursday as the vaccine maker's revenue outlook and ...